SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4,001.25 |
| Enterprise Value ($M) | 3,970.44 |
| Book Value ($M) | 349.02 |
| Book Value / Share | 1.48 |
| Price / Book | 11.46 |
| NCAV ($M) | 191.75 |
| NCAV / Share | 0.81 |
| Price / NCAV | 20.87 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.46 |
| Return on Assets (ROA) | 0.60 |
| Return on Equity (ROE) | 1.46 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.90 |
| Current Ratio | 5.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 331.41 |
| Assets | 488.68 |
| Liabilities | 139.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 426.45 |
| Operating Income | 138.98 |
| Net Income | 197.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Invesco Ltd. | 4.80 | -11.70 | |
| 13G/A | Vanguard Group Inc | 7.77 | 0.00 | |
| 13G | State Street Corp | 5.60 | ||
| 13G/A | BlackRock, Inc. | 16.40 | ||
| 13G | Millennium Management Llc | 0.60 | -78.03 | |
| 13G/A | Nuveen Asset Management, LLC | 2.17 | -2.77 | |
| 13G/A | Tiaa Cref Investment Management Llc | 2.17 | -2.77 | |
| 13G/A | Teachers Advisors, Llc | 2.17 | -2.77 | |
| 13G/A | Perceptive Advisors Llc | 2.80 | -45.94 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 830,924 | 2,942,859 | 28.24 | |
| 588,262 | 2,472,013 | 23.80 | |
| 933,457 | 3,612,210 | 25.84 | |
| 1,100,752 | 5,528,770 | 19.91 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACET – Adicet Bio, Inc. | ACIU – AC Immune SA |
| ACRV – Acrivon Therapeutics, Inc. | AFMD – Affimed N.V. |
| ALT – Altimmune, Inc. |
Financial data and stock pages provided by
Fintel.io